Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review

被引:1
|
作者
Kraj, Leszek [1 ,2 ]
Chmiel, Paulina [3 ]
Gryziak, Maciej [1 ]
Grabowska-Derlatka, Laretta [4 ]
Szymanski, Lukasz [2 ]
Wysokinska, Ewa [5 ]
机构
[1] Med Univ Warsaw, Univ Clin Ctr, Dept Oncol, PL-02091 Warsaw, Poland
[2] Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Mol Biol, PL-01447 Magdalenka, Poland
[3] Med Univ Warsaw, Univ Clin Ctr, PL-02091 Warsaw, Poland
[4] Med Univ Warsaw, Univ Clin Ctr, Dept Clin Radiol 2, PL-02091 Warsaw, Poland
[5] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
关键词
hepatocellular carcinoma; HCC; thrombocytopenia; platelets; outcome; tumor features; ENDOTHELIAL GROWTH-FACTOR; FACTOR-RECEPTOR-ALPHA; PLATELET COUNT; RADIOFREQUENCY ABLATION; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; HEPATITIS-B; CANCER; RESECTION; SIZE;
D O I
10.3390/cancers16071293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Currently, hepatocellular carcinoma (HCC) is one of the most prevalent oncological diagnoses worldwide. Despite intensive research into its pathogenesis and clinical course, numerous issues remain unresolved. In the presented meta-analysis and systematic review, we investigate the potential of blood platelet levels in patients with HCC for prognostic assessment. Blood platelets may play a significant role as an easily measurable laboratory parameter in assessing the prognosis of patients with HCC. Background: Platelets (PLT) have a role in the pathogenesis, progression, and prognosis of hepatocellular carcinoma (HCC) and could represent a readily measurable laboratory parameter to enhance the comprehensive evaluation of HCC patients. Methods: The PubMed, Web of Science, and Scopus databases were searched with a focus on survival as well as patient and tumor-specific characteristics in correlation to reported PLT counts. Survival outcomes were analyzed with both common-effect and random-effects models. The hazard ratio (HR) and its 95% confidence interval (CI) from analyzed trials were incorporated. Studies that did not provide survival data but focused on platelet count correlation with HCC characteristics were reviewed. Results: In total, 26 studies, including a total of 9403 patients, met our criteria. The results showed that thrombocytopenia in HCC patients was associated with poor overall survival (common-effect HR = 1.15, 95% CI: 1.06-1.25; random-effect HR = 1.30, 95% CI: 1.05-1.63). Moreover, three studies reveal significant correlations between PLT indices and tumor characteristics such as size, foci number, and etiology of HCC development. Conclusion: Our meta-analysis confirmed that PLT count could act as a prognostic marker in HCC, especially with a PLT count cut off <100 x 10(3)/mm(3). Further prospective studies focusing on the role of PLT in clearly defined subgroups are necessary.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Impact of HIV Infection on Survival in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Manthravadi, Sashidhar
    Shah, Raj
    Paleti, Swathi
    Sheshadri, Madhusudhana
    GASTROENTEROLOGY, 2016, 150 (04) : S1133 - S1133
  • [2] Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis
    Qing Pang
    Kai Qu
    Jian-Bin Bi
    Su-Shun Liu
    Jing-Yao Zhang
    Si-Dong Song
    Ting Lin
    Xin-Sen Xu
    Yong Wan
    Ming-Hui Tai
    Hao-Chen Liu
    Ya-Feng Dong
    Chang Liu
    World Journal of Gastroenterology, 2015, 21 (25) : 7895 - 7906
  • [3] Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis
    Pang, Qing
    Qu, Kai
    Bi, Jian-Bin
    Liu, Su-Shun
    Zhang, Jing-Yao
    Song, Si-Dong
    Lin, Ting
    Xu, Xin-Sen
    Wan, Yong
    Tai, Ming-Hui
    Liu, Hao-Chen
    Dong, Ya-Feng
    Liu, Chang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (25) : 7895 - 7906
  • [4] IMPACT OF WEIGHT PARAMETERS ON HEPATOCELLULAR CARCINOMA RECURRENCE AND SURVIVAL: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Wilder, Evan
    Jaspan, Vita
    Lin, Kevin
    Ndaw, Aziza
    Popov, Violeta
    GASTROENTEROLOGY, 2018, 154 (06) : S1243 - S1243
  • [5] Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Kamiliou, Aikaterini
    Lekakis, Vasileios
    Xynos, George
    Cholongitas, Evangelos
    CANCERS, 2024, 16 (05)
  • [6] Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-analysis and Systematic Review
    Sarmini, Muhammad Talal
    Alomari, Mohammad
    Al Momani, Laith
    Asfari, Mohammad Maysara
    Romero-Marrero, Carlos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S545 - S546
  • [7] Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review
    Khazaaleh, Shrouq
    Sarmini, Muhammad Talal
    Alomari, Mohammad
    Al Momani, Laith
    El Kurdi, Bara
    Asfari, Mohammad
    Almomani, Zain
    Romero-Marrero, Carlos
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
  • [8] THE SURVIVAL RATE OF HEPATOCELLULAR CARCINOMA IN ASIAN COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hassanipour, Soheil
    Vali, Mouhebat
    Gaffari-Fam, Saber
    Nikbakht, Hossein-Ali
    Abdzadeh, Elham
    Joukar, Farahnaz
    Pourshams, Akram
    Shafaghi, Afshin
    Malakoutikhah, Mahdi
    Arab-Zozani, Morteza
    Salehiniya, Hamid
    Mansour-Ghanaei, Fariborz
    EXCLI JOURNAL, 2020, 19 : 108 - 130
  • [9] MULTIDISCIPLINARY CARE FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    El Dahan, Karim Seif
    Reczek, Annika
    Daher, Darine
    Rich, Nicole E.
    Yang, Ju Dong
    Hsiehchen, David
    Molano, Maria del Pilar Bayona
    Parikh, Neehar D.
    Yopp, Adam
    Singal, Amit G.
    GASTROENTEROLOGY, 2023, 164 (06) : S302 - S302
  • [10] Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis
    Facciorusso, Antonio
    Abd El Aziz, Mohamed A.
    Sacco, Rodolfo
    CANCERS, 2020, 12 (01)